Tatsuyoshi Hirano
Nessuna posizione attualmente
Profilo
Tatsuyoshi Hirano served as President & Representative Director at UMN Pharma, Inc. and UNIGEN Inc. He also worked as Principal at Shin-Etsu Chemical Co., Ltd.
and as Chief Financial Officer & Executive Vice President at Toys "R" Us-Japan Ltd.
Hirano holds a graduate degree from The Johns Hopkins University and an undergraduate degree from the University of Hitotsubashi.
Precedenti posizioni note di Tatsuyoshi Hirano
Società | Posizione | Fine |
---|---|---|
UNIGEN Inc.
UNIGEN Inc. Pharmaceuticals: MajorHealth Technology UNIGEN Inc. engages in the contract manufacturing of biopharmaceuticals. It develops vaccines targeting influenza, norovirus, rotavirus and others. The company was founded on May 18, 2010 and is headquartered in Akita, Japan. | Presidente | - |
Toys "R" Us-Japan Ltd.
Toys "R" Us-Japan Ltd. Specialty StoresRetail Trade Toys "R" Us-Japan Ltd. operates a chain of toy and juvenile products retail stores. Its products include educational toys, dolls, plush toys and character toys, video games, bicycles, sporting goods, stationery, baby clothing, shoes, strollers, car seats, food and formula. The company was founded on November 21, 1989 and is headquartered in Kawasaki, Japan. | Direttore Finanziario/CFO | - |
SHIN-ETSU CHEMICAL CO., LTD. | Corporate Officer/Principal | - |
UMN PHARMA INC. | Direttore Finanziario/CFO | 01/08/2013 |
Formazione di Tatsuyoshi Hirano
University of Hitotsubashi | Undergraduate Degree |
The Johns Hopkins University | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
SHIN-ETSU CHEMICAL CO., LTD. | Process Industries |
Aziende private | 3 |
---|---|
UMN Pharma, Inc.
UMN Pharma, Inc. Pharmaceuticals: MajorHealth Technology UMN Pharma, Inc. engages in the development, manufacture, and sale of biopharmaceuticals. It operates through a following business division: Next-generation biopharmaceutical in-house development business and Biopharmaceutical contract manufacturing business. The Next-generation biopharmaceutical in-house development business engages in the research and development of next-generation logical vaccine by integrating next-generation biopharmaceutical drug substance manufacturing technology, adjuvant technology and drug delivery technology. The Biopharmaceutical contract manufacturing business offers study samples, investigational drugs, products, and various evaluation test results. The company was founded by Masahiro Michishita and Shuichi Kanazashi on April 20, 2004 and is headquartered in Akita, Japan. | Health Technology |
Toys "R" Us-Japan Ltd.
Toys "R" Us-Japan Ltd. Specialty StoresRetail Trade Toys "R" Us-Japan Ltd. operates a chain of toy and juvenile products retail stores. Its products include educational toys, dolls, plush toys and character toys, video games, bicycles, sporting goods, stationery, baby clothing, shoes, strollers, car seats, food and formula. The company was founded on November 21, 1989 and is headquartered in Kawasaki, Japan. | Retail Trade |
UNIGEN Inc.
UNIGEN Inc. Pharmaceuticals: MajorHealth Technology UNIGEN Inc. engages in the contract manufacturing of biopharmaceuticals. It develops vaccines targeting influenza, norovirus, rotavirus and others. The company was founded on May 18, 2010 and is headquartered in Akita, Japan. | Health Technology |
- Borsa valori
- Insiders
- Tatsuyoshi Hirano